The thrombotic potential of circulating tumor microemboli: Computational modeling of circulating tumor cell-induced coagulation

Kevin G. Phillips, Angela M. Lee, Garth W. Tormoen, Rachel A. Rigg, Anand Kolatkar, Madelyn Luttgen, Kelly Bethel, Lyudmila Bazhenova, Peter Kuhn, Paul Newton, Owen McCarty

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Thrombotic events can herald the diagnosis of cancer, preceding any cancer-related clinical symptoms. Patients with cancer are at a 4- to 7-fold increased risk of suffering from venous thromboembolism (VTE), with ∼7,000 patients with lung cancer presenting from VTEs. However, the physical biology underlying cancer-associated VTE remains poorly understood. Several lines of evidence suggest that the shedding of tissue factor (TF)-positive circulating tumor cells (CTCs) and microparticles from primary tumors may serve as a trigger for cancer-associated thrombosis. To investigate the potential direct and indirect roles of CTCs in VTE, we characterized thrombin generation by CTCs in an interactive numerical model coupling blood flow with advection-diffusion kinetics. Geometric measurements of CTCs isolated from the peripheral blood of a lung cancer patient prior to undergoing lobectomy formed the basis of the simulations. Singlet, doublet, and aggregate circulating tumor microemboli (CTM) were investigated in the model. Our numerical model demonstrated that CTM could potentiate occlusive events that drastically reduce blood flow and serve as a platform for the promotion of thrombin generation in flowing blood. These results provide a characterization of CTM dynamics in the vasculature and demonstrate an integrative framework combining clinical, biophysical, and mathematical approaches to enhance our understanding of CTCs and their potential direct and indirect roles in VTE formation.

Original languageEnglish (US)
Pages (from-to)C229-C236
JournalAmerican Journal of Physiology - Cell Physiology
Volume308
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Circulating Neoplastic Cells
Venous Thromboembolism
Neoplasms
Thrombin
Lung Neoplasms
Thromboplastin
Thrombosis

Keywords

  • Advection-diffusion equation
  • Circulating tumor microemboli
  • Coagulation
  • Lung cancer
  • Navier-Stokes equation
  • Tissue factor
  • Venous thromboembolism

ASJC Scopus subject areas

  • Cell Biology
  • Physiology

Cite this

The thrombotic potential of circulating tumor microemboli : Computational modeling of circulating tumor cell-induced coagulation. / Phillips, Kevin G.; Lee, Angela M.; Tormoen, Garth W.; Rigg, Rachel A.; Kolatkar, Anand; Luttgen, Madelyn; Bethel, Kelly; Bazhenova, Lyudmila; Kuhn, Peter; Newton, Paul; McCarty, Owen.

In: American Journal of Physiology - Cell Physiology, Vol. 308, No. 3, 2015, p. C229-C236.

Research output: Contribution to journalArticle

Phillips, KG, Lee, AM, Tormoen, GW, Rigg, RA, Kolatkar, A, Luttgen, M, Bethel, K, Bazhenova, L, Kuhn, P, Newton, P & McCarty, O 2015, 'The thrombotic potential of circulating tumor microemboli: Computational modeling of circulating tumor cell-induced coagulation', American Journal of Physiology - Cell Physiology, vol. 308, no. 3, pp. C229-C236. https://doi.org/10.1152/ajpcell.00315.2014
Phillips, Kevin G. ; Lee, Angela M. ; Tormoen, Garth W. ; Rigg, Rachel A. ; Kolatkar, Anand ; Luttgen, Madelyn ; Bethel, Kelly ; Bazhenova, Lyudmila ; Kuhn, Peter ; Newton, Paul ; McCarty, Owen. / The thrombotic potential of circulating tumor microemboli : Computational modeling of circulating tumor cell-induced coagulation. In: American Journal of Physiology - Cell Physiology. 2015 ; Vol. 308, No. 3. pp. C229-C236.
@article{9a22ac9e97844c109e2f15e6f7574cdc,
title = "The thrombotic potential of circulating tumor microemboli: Computational modeling of circulating tumor cell-induced coagulation",
abstract = "Thrombotic events can herald the diagnosis of cancer, preceding any cancer-related clinical symptoms. Patients with cancer are at a 4- to 7-fold increased risk of suffering from venous thromboembolism (VTE), with ∼7,000 patients with lung cancer presenting from VTEs. However, the physical biology underlying cancer-associated VTE remains poorly understood. Several lines of evidence suggest that the shedding of tissue factor (TF)-positive circulating tumor cells (CTCs) and microparticles from primary tumors may serve as a trigger for cancer-associated thrombosis. To investigate the potential direct and indirect roles of CTCs in VTE, we characterized thrombin generation by CTCs in an interactive numerical model coupling blood flow with advection-diffusion kinetics. Geometric measurements of CTCs isolated from the peripheral blood of a lung cancer patient prior to undergoing lobectomy formed the basis of the simulations. Singlet, doublet, and aggregate circulating tumor microemboli (CTM) were investigated in the model. Our numerical model demonstrated that CTM could potentiate occlusive events that drastically reduce blood flow and serve as a platform for the promotion of thrombin generation in flowing blood. These results provide a characterization of CTM dynamics in the vasculature and demonstrate an integrative framework combining clinical, biophysical, and mathematical approaches to enhance our understanding of CTCs and their potential direct and indirect roles in VTE formation.",
keywords = "Advection-diffusion equation, Circulating tumor microemboli, Coagulation, Lung cancer, Navier-Stokes equation, Tissue factor, Venous thromboembolism",
author = "Phillips, {Kevin G.} and Lee, {Angela M.} and Tormoen, {Garth W.} and Rigg, {Rachel A.} and Anand Kolatkar and Madelyn Luttgen and Kelly Bethel and Lyudmila Bazhenova and Peter Kuhn and Paul Newton and Owen McCarty",
year = "2015",
doi = "10.1152/ajpcell.00315.2014",
language = "English (US)",
volume = "308",
pages = "C229--C236",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - The thrombotic potential of circulating tumor microemboli

T2 - Computational modeling of circulating tumor cell-induced coagulation

AU - Phillips, Kevin G.

AU - Lee, Angela M.

AU - Tormoen, Garth W.

AU - Rigg, Rachel A.

AU - Kolatkar, Anand

AU - Luttgen, Madelyn

AU - Bethel, Kelly

AU - Bazhenova, Lyudmila

AU - Kuhn, Peter

AU - Newton, Paul

AU - McCarty, Owen

PY - 2015

Y1 - 2015

N2 - Thrombotic events can herald the diagnosis of cancer, preceding any cancer-related clinical symptoms. Patients with cancer are at a 4- to 7-fold increased risk of suffering from venous thromboembolism (VTE), with ∼7,000 patients with lung cancer presenting from VTEs. However, the physical biology underlying cancer-associated VTE remains poorly understood. Several lines of evidence suggest that the shedding of tissue factor (TF)-positive circulating tumor cells (CTCs) and microparticles from primary tumors may serve as a trigger for cancer-associated thrombosis. To investigate the potential direct and indirect roles of CTCs in VTE, we characterized thrombin generation by CTCs in an interactive numerical model coupling blood flow with advection-diffusion kinetics. Geometric measurements of CTCs isolated from the peripheral blood of a lung cancer patient prior to undergoing lobectomy formed the basis of the simulations. Singlet, doublet, and aggregate circulating tumor microemboli (CTM) were investigated in the model. Our numerical model demonstrated that CTM could potentiate occlusive events that drastically reduce blood flow and serve as a platform for the promotion of thrombin generation in flowing blood. These results provide a characterization of CTM dynamics in the vasculature and demonstrate an integrative framework combining clinical, biophysical, and mathematical approaches to enhance our understanding of CTCs and their potential direct and indirect roles in VTE formation.

AB - Thrombotic events can herald the diagnosis of cancer, preceding any cancer-related clinical symptoms. Patients with cancer are at a 4- to 7-fold increased risk of suffering from venous thromboembolism (VTE), with ∼7,000 patients with lung cancer presenting from VTEs. However, the physical biology underlying cancer-associated VTE remains poorly understood. Several lines of evidence suggest that the shedding of tissue factor (TF)-positive circulating tumor cells (CTCs) and microparticles from primary tumors may serve as a trigger for cancer-associated thrombosis. To investigate the potential direct and indirect roles of CTCs in VTE, we characterized thrombin generation by CTCs in an interactive numerical model coupling blood flow with advection-diffusion kinetics. Geometric measurements of CTCs isolated from the peripheral blood of a lung cancer patient prior to undergoing lobectomy formed the basis of the simulations. Singlet, doublet, and aggregate circulating tumor microemboli (CTM) were investigated in the model. Our numerical model demonstrated that CTM could potentiate occlusive events that drastically reduce blood flow and serve as a platform for the promotion of thrombin generation in flowing blood. These results provide a characterization of CTM dynamics in the vasculature and demonstrate an integrative framework combining clinical, biophysical, and mathematical approaches to enhance our understanding of CTCs and their potential direct and indirect roles in VTE formation.

KW - Advection-diffusion equation

KW - Circulating tumor microemboli

KW - Coagulation

KW - Lung cancer

KW - Navier-Stokes equation

KW - Tissue factor

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84922212663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922212663&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00315.2014

DO - 10.1152/ajpcell.00315.2014

M3 - Article

C2 - 25411332

AN - SCOPUS:84922212663

VL - 308

SP - C229-C236

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 3

ER -